Question

A 56-year-old woman with type 2 diabetes, BMI 33 kg/m² and HbA1c 65 mmol/mol is on maximum tolerated dose of Metformin but continues to have poor glycaemic control. According to NICE NG28, which drug class is preferred as the next addition in someone with high cardiovascular risk?

Accepted Answer

SGLT2 inhibitor such as Empagliflozin.

Answer

Sulfonylurea such as Gliclazide.

Answer

DPP-4 inhibitor such as Sitagliptin.

Answer

Thiazolidinedione such as Pioglitazone.

Answer

Basal insulin.

Practice question

A 56-year-old woman with type 2 diabetes, BMI 33 kg/m² and HbA1c 65 mmol/mol is on maximum tolerated dose of Metformin but continues to have poor glycaemic control. According to NICE NG28, which drug class is preferred as the next addition in someone with high cardiovascular risk?